Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation

L. Addis, J.W. Ahn, R. Dobson, A. Dixit, C.M. Ogilvie, D. Pinto, A.K. Vaags, H. Coon, P. Chaste, Scott Wilson, J.R. Parr, J. Andrieux, B. Lenne, Z. Tumer, V. Leuzzi, K. Aubell, H. Koillinen, S. Curran, C.R. Marshall, S.W. Scherer & 3 others L.J. Strug, D.A. Collier, D.K. Pal

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

© 2015 WILEY PERIODICALS, INC.. Copy-number variations (CNVs) are important in the aetiology of neurodevelopmental disorders and show broad phenotypic manifestations. We compared the presence of small CNVs disrupting the ELP4-PAX6 locus in 4,092 UK individuals with a range of neurodevelopmental conditions, clinically referred for array comparative genomic hybridization, with WTCCC controls (n = 4,783). The phenotypic analysis was then extended using the DECIPHER database. We followed up association using an autism patient cohort (n = 3,143) compared with six additional control groups (n = 6,469). In the clinical discovery series, we identified eight cases with ELP4 deletions, and one with a partial duplication of ELP4 and PAX6. These cases were referred for neurological phenotypes including language impairment, developmental delay, autism, and epilepsy. Six further cases with a primary diagnosis of autism spectrum disorder (ASD) and similar secondary phenotypes were identified with ELP4 deletions, as well as another six (out of nine) with neurodevelopmental phenotypes from DECIPHER. CNVs at ELP4 were only present in 1/11,252 controls. We found a significant excess of CNVs in discovery cases compared with controls, P = 7.5 × 10-3, as well as for autism, P = 2.7 × 10-3. Our results suggest that ELP4 deletions are highly likely to be pathogenic, predisposing to a range of neurodevelopmental phenotypes from ASD to language impairment and epilepsy. We have identified a significant excess (p = 7.5 × 10-3) of small deletions (shown as red lines on the figure) at the PAX6-ELP4 locus, 11p13, in three cohorts of patients with neurodevelopmental disorders. The deletions predispose to a range of phenotypes including autism spectrum disorder, language impairment, mental retardation and epilepsy, and likely disrupt the functions of the Elongator protein complex and/or the transcription factor PAX6.
Original languageEnglish
Pages (from-to)842-850
JournalHuman Mutation
Volume36
Issue number9
DOIs
Publication statusPublished - 2015

Fingerprint

Intellectual Disability
Language
Phenotype
Autistic Disorder
Epilepsy
Comparative Genomic Hybridization
Autism Spectrum Disorder
Databases
Control Groups
Proteins
Neurodevelopmental Disorders

Cite this

Addis, L., Ahn, J. W., Dobson, R., Dixit, A., Ogilvie, C. M., Pinto, D., ... Pal, D. K. (2015). Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation. Human Mutation, 36(9), 842-850. https://doi.org/10.1002/humu.22816
Addis, L. ; Ahn, J.W. ; Dobson, R. ; Dixit, A. ; Ogilvie, C.M. ; Pinto, D. ; Vaags, A.K. ; Coon, H. ; Chaste, P. ; Wilson, Scott ; Parr, J.R. ; Andrieux, J. ; Lenne, B. ; Tumer, Z. ; Leuzzi, V. ; Aubell, K. ; Koillinen, H. ; Curran, S. ; Marshall, C.R. ; Scherer, S.W. ; Strug, L.J. ; Collier, D.A. ; Pal, D.K. / Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation. In: Human Mutation. 2015 ; Vol. 36, No. 9. pp. 842-850.
@article{1ffeaacaa447476dbbce2046f82f4709,
title = "Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation",
abstract = "{\circledC} 2015 WILEY PERIODICALS, INC.. Copy-number variations (CNVs) are important in the aetiology of neurodevelopmental disorders and show broad phenotypic manifestations. We compared the presence of small CNVs disrupting the ELP4-PAX6 locus in 4,092 UK individuals with a range of neurodevelopmental conditions, clinically referred for array comparative genomic hybridization, with WTCCC controls (n = 4,783). The phenotypic analysis was then extended using the DECIPHER database. We followed up association using an autism patient cohort (n = 3,143) compared with six additional control groups (n = 6,469). In the clinical discovery series, we identified eight cases with ELP4 deletions, and one with a partial duplication of ELP4 and PAX6. These cases were referred for neurological phenotypes including language impairment, developmental delay, autism, and epilepsy. Six further cases with a primary diagnosis of autism spectrum disorder (ASD) and similar secondary phenotypes were identified with ELP4 deletions, as well as another six (out of nine) with neurodevelopmental phenotypes from DECIPHER. CNVs at ELP4 were only present in 1/11,252 controls. We found a significant excess of CNVs in discovery cases compared with controls, P = 7.5 × 10-3, as well as for autism, P = 2.7 × 10-3. Our results suggest that ELP4 deletions are highly likely to be pathogenic, predisposing to a range of neurodevelopmental phenotypes from ASD to language impairment and epilepsy. We have identified a significant excess (p = 7.5 × 10-3) of small deletions (shown as red lines on the figure) at the PAX6-ELP4 locus, 11p13, in three cohorts of patients with neurodevelopmental disorders. The deletions predispose to a range of phenotypes including autism spectrum disorder, language impairment, mental retardation and epilepsy, and likely disrupt the functions of the Elongator protein complex and/or the transcription factor PAX6.",
author = "L. Addis and J.W. Ahn and R. Dobson and A. Dixit and C.M. Ogilvie and D. Pinto and A.K. Vaags and H. Coon and P. Chaste and Scott Wilson and J.R. Parr and J. Andrieux and B. Lenne and Z. Tumer and V. Leuzzi and K. Aubell and H. Koillinen and S. Curran and C.R. Marshall and S.W. Scherer and L.J. Strug and D.A. Collier and D.K. Pal",
year = "2015",
doi = "10.1002/humu.22816",
language = "English",
volume = "36",
pages = "842--850",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss",
number = "9",

}

Addis, L, Ahn, JW, Dobson, R, Dixit, A, Ogilvie, CM, Pinto, D, Vaags, AK, Coon, H, Chaste, P, Wilson, S, Parr, JR, Andrieux, J, Lenne, B, Tumer, Z, Leuzzi, V, Aubell, K, Koillinen, H, Curran, S, Marshall, CR, Scherer, SW, Strug, LJ, Collier, DA & Pal, DK 2015, 'Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation' Human Mutation, vol. 36, no. 9, pp. 842-850. https://doi.org/10.1002/humu.22816

Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation. / Addis, L.; Ahn, J.W.; Dobson, R.; Dixit, A.; Ogilvie, C.M.; Pinto, D.; Vaags, A.K.; Coon, H.; Chaste, P.; Wilson, Scott; Parr, J.R.; Andrieux, J.; Lenne, B.; Tumer, Z.; Leuzzi, V.; Aubell, K.; Koillinen, H.; Curran, S.; Marshall, C.R.; Scherer, S.W.; Strug, L.J.; Collier, D.A.; Pal, D.K.

In: Human Mutation, Vol. 36, No. 9, 2015, p. 842-850.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation

AU - Addis, L.

AU - Ahn, J.W.

AU - Dobson, R.

AU - Dixit, A.

AU - Ogilvie, C.M.

AU - Pinto, D.

AU - Vaags, A.K.

AU - Coon, H.

AU - Chaste, P.

AU - Wilson, Scott

AU - Parr, J.R.

AU - Andrieux, J.

AU - Lenne, B.

AU - Tumer, Z.

AU - Leuzzi, V.

AU - Aubell, K.

AU - Koillinen, H.

AU - Curran, S.

AU - Marshall, C.R.

AU - Scherer, S.W.

AU - Strug, L.J.

AU - Collier, D.A.

AU - Pal, D.K.

PY - 2015

Y1 - 2015

N2 - © 2015 WILEY PERIODICALS, INC.. Copy-number variations (CNVs) are important in the aetiology of neurodevelopmental disorders and show broad phenotypic manifestations. We compared the presence of small CNVs disrupting the ELP4-PAX6 locus in 4,092 UK individuals with a range of neurodevelopmental conditions, clinically referred for array comparative genomic hybridization, with WTCCC controls (n = 4,783). The phenotypic analysis was then extended using the DECIPHER database. We followed up association using an autism patient cohort (n = 3,143) compared with six additional control groups (n = 6,469). In the clinical discovery series, we identified eight cases with ELP4 deletions, and one with a partial duplication of ELP4 and PAX6. These cases were referred for neurological phenotypes including language impairment, developmental delay, autism, and epilepsy. Six further cases with a primary diagnosis of autism spectrum disorder (ASD) and similar secondary phenotypes were identified with ELP4 deletions, as well as another six (out of nine) with neurodevelopmental phenotypes from DECIPHER. CNVs at ELP4 were only present in 1/11,252 controls. We found a significant excess of CNVs in discovery cases compared with controls, P = 7.5 × 10-3, as well as for autism, P = 2.7 × 10-3. Our results suggest that ELP4 deletions are highly likely to be pathogenic, predisposing to a range of neurodevelopmental phenotypes from ASD to language impairment and epilepsy. We have identified a significant excess (p = 7.5 × 10-3) of small deletions (shown as red lines on the figure) at the PAX6-ELP4 locus, 11p13, in three cohorts of patients with neurodevelopmental disorders. The deletions predispose to a range of phenotypes including autism spectrum disorder, language impairment, mental retardation and epilepsy, and likely disrupt the functions of the Elongator protein complex and/or the transcription factor PAX6.

AB - © 2015 WILEY PERIODICALS, INC.. Copy-number variations (CNVs) are important in the aetiology of neurodevelopmental disorders and show broad phenotypic manifestations. We compared the presence of small CNVs disrupting the ELP4-PAX6 locus in 4,092 UK individuals with a range of neurodevelopmental conditions, clinically referred for array comparative genomic hybridization, with WTCCC controls (n = 4,783). The phenotypic analysis was then extended using the DECIPHER database. We followed up association using an autism patient cohort (n = 3,143) compared with six additional control groups (n = 6,469). In the clinical discovery series, we identified eight cases with ELP4 deletions, and one with a partial duplication of ELP4 and PAX6. These cases were referred for neurological phenotypes including language impairment, developmental delay, autism, and epilepsy. Six further cases with a primary diagnosis of autism spectrum disorder (ASD) and similar secondary phenotypes were identified with ELP4 deletions, as well as another six (out of nine) with neurodevelopmental phenotypes from DECIPHER. CNVs at ELP4 were only present in 1/11,252 controls. We found a significant excess of CNVs in discovery cases compared with controls, P = 7.5 × 10-3, as well as for autism, P = 2.7 × 10-3. Our results suggest that ELP4 deletions are highly likely to be pathogenic, predisposing to a range of neurodevelopmental phenotypes from ASD to language impairment and epilepsy. We have identified a significant excess (p = 7.5 × 10-3) of small deletions (shown as red lines on the figure) at the PAX6-ELP4 locus, 11p13, in three cohorts of patients with neurodevelopmental disorders. The deletions predispose to a range of phenotypes including autism spectrum disorder, language impairment, mental retardation and epilepsy, and likely disrupt the functions of the Elongator protein complex and/or the transcription factor PAX6.

U2 - 10.1002/humu.22816

DO - 10.1002/humu.22816

M3 - Article

VL - 36

SP - 842

EP - 850

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 9

ER -